The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Pharmacology of Antidepressants—Characteristics of the Ideal Drug
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Depression, Disability Days, and Days Lost From Work in a Prospective Epidemiologic Survey
Broadhead, W. E. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450190056028 · Cited by 1,237
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Harrison's Principles of Internal Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-918_1 · Cited by 1,094
Highly potent and selective ligands for histamine H3-receptors
Arrang, J.-M., Garbarg, M., Lancelo, J.-C., Lecomte, J.-M., Pollard, H., Robba, M., Schunack, W., & Schwartz, J.-C. (1987) · Nature · doi:10.1038/327117a0 · Cited by 903
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Increasing Rates of Depression
Klerman, G. L. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420150079041 · Cited by 779
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
KUHN, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615
Richelson, E., & Pfenning, M. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90403-5 · Cited by 526
Self-citationMode of action of antidepressant drugs
Sulser, F., Vetulani, J., & Mobley, P. L. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90226-5 · Cited by 515
Crewe, H., Lennard, M., Tucker, G., Woods, F., & Haddock, R. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04134.x · Cited by 469
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
Bolden-Watson, C., & Richelson, E. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90194-8 · Cited by 390
Self-citationFluvoxamine is a potent inhibitor of cytochrome P4501A2
Brøsen, K., Skjelbo, E., Rasmussen, B. B., Poulsen, H. E., & Loft, S. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90272-x · Cited by 374
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.11.1351 · Cited by 367
The Efficacy of Antidepressant Drugs: A Review of Research (1958 to 1972)
Morris, J. B. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760110083010 · Cited by 353
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Cusack, B., Nelson, A., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349
Self-citationAntagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
Richelson, E., & Nelson, A. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21446-x · Cited by 341
Self-citationCardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review
Glassman, A. H. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320095011 · Cited by 269
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
Inhibition by fluoxetine of cytochrome P450 2D6 activity
Otton, S. V., Wu, D., Joffe, R. T., Cheung, S. W., & Sellers, E. M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.43 · Cited by 257
Neurobiological Mechanisms Involved in Antidepressant Therapies
Briley, M., & Moret, C. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199310000-00002 · Cited by 210
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.2.155 · Cited by 207
Klamerus, K. J., Moloney, K., Rudolph, R. L., Sisenwine, S. F., Jusko, W. J., & Chiang, S. T. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb03875.x · Cited by 201
Walker, E. A., Katon, W. J., Jemelka, R. P., & Roy-Byrne, P. P. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90133-v · Cited by 195
Pharmacokinetics of Desipramine Coadministered With Sertraline or Fluoxetine
PRESKORN, S. H., ALDERMAN, J., CHUNG, M., HARRISON, W., MESSIG, M., & HARRIS, S. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00002 · Cited by 190
Inhibitors of imipramine metabolism by human liver microsomes.
Skjelbo, E., & Brosen, K. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04133.x · Cited by 163
A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia
Hellerstein, D. J., Yanowitch, P., Rosenthal, J., Samstag, L. W., Maurer, M., Kasch, K. L., Burrows, L., Poster, M., Cantillon, M., & Winston, A. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1169 · Cited by 141
Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder
Murphy, D. L., Zohar, J., Benkelfat, C., Pato, M. T., Pigott, T. A., & Insel, T. R. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291721 · Cited by 138
Clinical epidemiology of suicide.
Klerman, G. L. (1987) · PubMed · Cited by 134
Fluoxetine kinetics and protein binding in normal and impaired renal function
Aronoff, G. R., Bergstrom, R. F., Pottratz, S. T., Sloan, R. S., Wolen, R. L., & Lemberger, L. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.152 · Cited by 113
Evans, L., Kenardy, J. A., Schneider, P., & Hoey, H. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb02666.x · Cited by 112
Comparison of SPECT applications in neurology and psychiatry.
Devous, M. D. (1992) · PubMed · Cited by 107
Review of the cardiovascular effects of heterocyclic antidepressants.
Glassman, A. H., & Preudʼhomme, X. (1993) · PubMed · Cited by 99
Fluoxetine and extrapyramidal side effects
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1352a · Cited by 99
Mode of action of antidepressant drugs.
Cole, J. O., Branconnier, R. J., Salomon, M. I., & Dessain, E. C. (1983) · PubMed · Cited by 96
Steiner, W., & Fontaine, R. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90287-8 · Cited by 95
The safety profile of paroxetine.
Wf, B., & Blumhardt, C. L. (1992) · PubMed · Cited by 92
Recent pharmacologic advances in antidepressant therapy for the elderly.
Preskorn, S. H. (1993) · PubMed · Cited by 87
Stanton, T., Watson, C. B., Cusack, B. M., & Richelson, E. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90211-e · Cited by 84
Self-citationPossible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor Interaction
BEASLEY, C. M., Masica, D. N., Heiligenstein, J. H., Wheadon, D. E., & Zerbe, R. L. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00003 · Cited by 82
Therapeutic Drug Monitoring: Principles and Practice
Preskorn, S., Burke, M. J., & Fast, G. A. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30167-9 · Cited by 81
Fourier's view on homosexuality
Plaut, E. A. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1352b · Cited by 79
Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose
Laizure, S. C., DeVane, C. L., Stewart, J. T., Dommisse, C. S., & Lai, A. A. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.228 · Cited by 77
Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients
Härtter, S., Wetzel, H., Hammes, E., & Hiemke, C. (1993) · Psychopharmacology · doi:10.1007/bf02251285 · Cited by 73
Caccia, S., Fong, M. H., Garattini, S. K., & Zanini, M. G. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb04807.x · Cited by 70
Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly Subjects
de Vries, M. H., Raghoebar, M., Mathlener, I. S., & van Harten, J. (1992) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199212000-00010 · Cited by 66
Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly.
Bayer, A. J., Pathy, M., & Ankier, S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02180.x · Cited by 65
Antidepressants and Brain Neurochemistry
Richelson, E. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62747-5 · Cited by 63
Self-citationManagement of Monoamine Oxidase Inhibitor-Associated Insomnia with Trazodone
Nierenberg, A. A., & Keck, P. E. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198902000-00009 · Cited by 57
Gardier, A. M., Poul, E. L., Trouvin, J., Chanut, E., Dessalles, M. C., & Jacquot, C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00821-3 · Cited by 49
Potential Indications for the Selective Serotonin Reuptake Inhibitors
Boyer, W. F. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206005-00001 · Cited by 45
Adverse reactions suggesting amoxapine-induced dopamine blockade
Steele, T. E. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1500 · Cited by 43
Dawling, S., Crome, P., & Braithwaite, R. A. (1980) · Clinical Pharmacokinetics · doi:10.2165/00003088-198005040-00007 · Cited by 42
Kline, M. D. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.804 · Cited by 40
Pharmacokinetics and Biological Effects of Nortriptyline in Man
Sjöqvist, F., Alexanderson, B., Åsberg, M., Bertilsson, L., Borgå, O., Hamberger, B., & Tuck, D. (1971) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1971.tb03306.x · Cited by 39
Abernethy, D. R., Greenblatt, D. J., & Shader, R. I. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.42 · Cited by 39
Sertraline and extrapyramidal side effects
Shihabuddin, L., & Rapport, D. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.288b · Cited by 39
Bergstrom, R. F., Beasley, C. M., Levy, N. B., Blumenfield, M., & Lemberger, L. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00009 · Cited by 35
Nyström, C., & Hällström, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02563.x · Cited by 27
Histamine receptors in the central nervous system
Timmerman, H. (1989) · Pharmacy World & Science · doi:10.1007/bf01959461 · Cited by 25
Antidepressants: A Clinical Update for Medical Practitioners
Richardson, J. W., & Richelson, E. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61429-3 · Cited by 23
Self-citationTreatment of dementias : a new generation of progress
Meyer, E. M. (1992) · Medical Entomology and Zoology · Cited by 22
Trimipramine—an Atypical Neuroleptic?
Eikmeier, G., Berger, M., Lodemann, E., Muszynski, K., Kaumeier, S., & Gastpar, M. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100630-00003 · Cited by 19
Reversing anorgasmia associated with serotonin uptake inhibitors
Segraves, R. T. (1991) · JAMA · doi:10.1001/jama.266.16.2279a · Cited by 7
Muscarinic Receptors: Molecular Biology and Neuropsychopharmacology
Richelson, E. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_1 · Cited by 2
Self-citation
Cited by
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Self-citationPharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Wisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666
Royall, D. R., Lauterbach, E. C., Cummings, J. L., Reeve, A., Rummans, T. A., Kaufer, D. I., LaFrance, Jr., & Coffey, C. E. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.4.377 · Cited by 637
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Metadata
- Authors
- RICHELSON, E.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 1994-11
- Volume
- 69
- Issue
- 11
- Pages
- 1069-1081
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2121086028
- Cited by
- 257
- References
- 68
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.